Drugs / Tumor vaccine-induced specific T-cell
Tumor vaccine-induced specific T-cell
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07329894 | Feb 2026 → Aug 2027 expected | digestive system cancer | Beijing GoBroad Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tumor vaccine-induced specific T-cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07329894 ↗ |
| Modality | Cell therapy | “Adoptive T Cell Therapy” NCT07329894 ↗ |